Navigation Links
PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
Date:7/24/2012

BRANFORD, Conn., July 24, 2012, /PRNewswire-iReach/ -- PhoenixSongs Biologicals, Inc. today announced the release of their novel state of the art neural cell culture media system optimized for the growth and differentiation of human, rat, and mouse neural stem cells isolated from donated tissue, induced pluripotency stem (iPS) cells, or embryonic stem (ES) cells.  These unique media formulations enable expansion of neural stem cell populations to a scale never before achieved and reliably differentiate neural stem cells into functionally mature neurons, astrocytes, and oligodendrocytes, with electrically active neurons that have abundant and mature excitatory and inhibitory synapses.

Unlike larger manufactures of similar neural media products, all media products formulated and produced at PhoenixSongs are optimized to support specific lineage stages of cells from proliferation of the neural stem cells through development (in vitro differentiation) into mature cell fates focusing on functional endpoints of the mature terminally differentiated cell types.   Each batch of media is put through rigorous quality control testing for sterility and function to ensure that each bottle of media meets the highest industry performance QC standards before it is released for sale. All media formulations are produced by PhoenixSongs with pre-qualified reagents for consistent performance across all batches.  Each media is complete, including a basal liquid media, a frozen serum-free supplement, and all the growth factors required for growth and differentiation of the stem cells into neurons as well as maintenance and survival of the neurons in long-term culture.

These Neural Stem Cell Growth, Transition, and Differentiation Media were originally formulated using off-the-shelf products (such as Neural Basal and DMEM/F12 media, B27, and N2 supplements) to produce neural stem cells from mouse ES cells then differentiated into neural cultures that were used in an industry-first high throughput screen where 2.4 million compounds were screened to identify candidate drugs for treatment of schizophrenia. The growth media enabled expansion of the neural stem cells to a scale so that an entire screen was run in 384-well format from one batch of ES cell-derived neural stem cells that were differentiated into neurons.  The Neural Differentiation media was formulated to include components that not only differentiated the stem cells into neurons, astrocytes, and oligodendrocytes, but also supported survival and function of the neurons in long-term culture.  (published in <cite>J. Biol. Chem. </cite>2010 285: 17209-17217).

PhoenixSongs further optimized the aforementioned media formulations making it possible to expand human neural stem cells isolated from all sources to the same scale achieved with the ES cell derived neural stem cells while maintaining the differentiation potential beyond passage 15.   Since the PhoenixSongs' media are complete, there would be no need for researchers to source additional components. 

Neuroscientists can now purchase these novel complete media from PhoenixSongs online.  www.phoenixsongsbio.com.

"We are extremely pleased with the customer and collaborator feedback we have received year to date on our neural stem cell media products.  Many neuroscientists have struggled with batch variation from their traditional media component vendors.  In many cases suppliers have not pre-qualified their media for neural stem cell growth and differentiation, but at PhoenixSongs all media are tested with progenitor cells to ensure its performance.  Not only does our neural stem cell media remove variation, but it allows neuroscience biologists to focus on their research and production." said Richard Malavarca, President of PhoenixSongs Biologicals, Inc. on the full scale release of their neural media portfolio.

About Richard Malavarca - Mr. Malavarca was a co-founder of Specialty Media, Inc. a recognized leader in custom media production that was purchased by Millipore in 2005.  At Specialty Media, Rich lead the formulation and production of the first commercially available novel embryo culture media in the late 1980s.  He also served as EVP of Media Development at GigaCyte & Triangle Research Labs, LLC for over 2 years, and now serves as President of Phoenix Songs Biologicals, Inc. 

 About PhoenixSongs Biologicals, Inc. – Headquartered in Branford, Connecticut, Phoenix Songs was founded by Dr. Lola Reid in 2009 with a focus on stem cell research and a goal of making stem-cell models commercially available to the global research community. 

PhoenixSongs Contact:
Marsha Roach
mroach@pheonixsongsbio.com   
203-433-4329

Media Contact: Marsha Roach PhoenixSongs Biologicals, 860-608-0439, mroach@phoenixsongsbio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE PhoenixSongs Biologicals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... 20, 2017 , ... Proscia Inc. , a data ... of whole slide imaging solutions, are hosting a pre-conference workshop at the ... a Best-in-Class Strategy for Digital Pathology,” will feature Proscia CEO, David West Jr., ...
(Date:9/20/2017)... ... September 20, 2017 , ... RoviSys, a leading ... today the opening of an office in Taipei, Taiwan. This new location allows ... while developing new relationships in the region. Located in the Neihu area of ...
(Date:9/19/2017)... Poway, CA (PRWEB) , ... September 19, 2017 , ... VetStem Biopharma ’s CEO ... H. Riordan PA, PhD in Riordan’s new book "Stem Cell Therapy: A Rising Tide". ... past 14 years. They bonded over an interest in the potential of stem cell ...
(Date:9/19/2017)... ... September 19, 2017 , ... Avomeen Analytical Services, ... of its 2017 Science Student Award. The scholarship program is dedicated to helping ... service defray the costs of obtaining their science education. , Avomeen began the ...
Breaking Biology Technology:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):